logo for Aprecia Pharmaceuticals

Aprecia Pharmaceuticals

Drug Stores & Pharmacies · Ohio, United States · 84 Employees

View Company Info for Free

About

Headquarters

10901 Kenwood Rd, Blue Ash, Ohio, 45242, United...

Revenue

$30.3 Million

Industry

Drug Stores & Pharmacies Retail

Highlights

$226.9M

Total Funding Amount

$20M

Most Recent Funding Amount

10

Number of Funding Rounds

Who is Aprecia Pharmaceuticals

Aprecia is an emerging pharmaceutical company that expects to use its proprietary ZipDose Technology to transform the way people take medicine. Aprecia believes it is the first and only company in the world to utilize three-dimensional printing (3DP) technology to develop and manufacture pharmaceutical products on a commercial scale. Aprecia plans to introduce multiple highly prescribed, high dose medications utilizing ZipDose Technology in the coming years. The company's initial focus is on the central nervous system therapeutic area where there is a need for medicines that are easy to take. Aprecia's mission is to improve real-world outcomes by transforming the way medicine is experienced. The company is privately owned, with affiliates of Prasco, LLC and the Arington family holding a controlling interest.Read more

Aprecia Pharmaceuticals's Social MediaPopular SearchesAprecia Pharmaceuticals LLCAprecia Pharmaceuticals CoAprecia PharmaceuticalsApreciaAprecia Pharmaceuticals - CoSIC Code 28,283NAICS Code 32,325Show more

Aprecia Pharmaceuticals Org Chart

Owen Murray

Chief Executive Officer

PhoneEmail
Kyle Smith
Kyle Smith

President & Chief Operating Officer

PhoneEmail
Jaedeok Yoo

Chief Technology Officer

PhoneEmail

PhoneEmail

Similar Companies to Aprecia Pharmaceuticals

Aprecia Pharmaceuticals Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateJul 04, 2016
RoundDebt
Amount$20M
InvestorsHercules Capital, Inc
Funding DateJan 25, 2016
RoundPrivate Equity
Amount$35M
InvestorsDeerfield
Funding DateJan 12, 2016
RoundPrivate Equity
Amount$79M
Investors
See More

$226.9M

Total Funding Amount

$20M

Most Recent Funding Amount

10

Number of Funding Rounds

Aprecia Pharmaceuticals Tech Stack

A closer look at the technologies used by Aprecia Pharmaceuticals

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Aprecia Pharmaceuticals News & Media

Read more news

Frequently Asked Questions regarding Aprecia Pharmaceuticals

Where is Aprecia Pharmaceuticals located?
Aprecia Pharmaceuticals's headquarters are located at 10901 Kenwood Rd, Blue Ash, Ohio, 45242, United States
What is Aprecia Pharmaceuticals's official website?
Aprecia Pharmaceuticals's official website is www.aprecia.com
What is Aprecia Pharmaceuticals's Revenue?
Aprecia Pharmaceuticals's revenue is $30.3 Million
What is Aprecia Pharmaceuticals's SIC code?
Aprecia Pharmaceuticals's SIC: 28,283
What is Aprecia Pharmaceuticals's NAICS code?
Aprecia Pharmaceuticals's NAICS: 32,325
How many employees does Aprecia Pharmaceuticals have?
Aprecia Pharmaceuticals has 84 employees
What industry does Aprecia Pharmaceuticals belong to?
Aprecia Pharmaceuticals is in the industry of: Drug Stores & Pharmacies, Retail
What is Aprecia Pharmaceuticals competition?
Aprecia Pharmaceuticals top competitors include: BioZone Laboratories Inc, LATITUDE Pharmaceuticals Inc, Heron Therapeutics Inc, Impel Pharmaceuticals
What technology does Aprecia Pharmaceuticals use?
Some of the popular technologies that Aprecia Pharmaceuticals uses are: Power BI, Autodesk AutoCAD, RSLogix, Microsoft Excel
Who is the CEO of Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals's CEO is Don Wetherhold
Who is the CFO of Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals's CFO is Michael Rohlfs
Who is the CTO of Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals's CTO is Jaedeok Yoo
What does Aprecia Pharmaceuticals do?

Aprecia is an emerging pharmaceutical company that expects to use its proprietary ZipDose Technology to transform the way people take medicine. Aprecia believes it is the first and only company in the world to utilize three-dimensional printing (3DP) technology to develop and manufacture pharmaceutical products on a commercial scale. Aprecia plans... to introduce multiple highly prescribed, high dose medications utilizing ZipDose Technology in the coming years. The company's initial focus is on the central nervous system therapeutic area where there is a need for medicines that are easy to take. Aprecia's mission is to improve real-world outcomes by transforming the way medicine is experienced. The company is privately owned, with affiliates of Prasco, LLC and the Arington family holding a controlling interest.Read More

What are Aprecia Pharmaceuticals social media links?
Aprecia Pharmaceuticals Linkedin page Aprecia Pharmaceuticals Twitter page
How much funding has Aprecia Pharmaceuticals raised to date?
Aprecia Pharmaceuticals has raised $226.9 Million in 10 funding rounds
When was the last funding round for Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals closed its last funding round on Jul 04, 2016 with the amount of $20 Million
Who invested in Aprecia Pharmaceuticals?
Aprecia Pharmaceuticals has 10 investors including Deerfield, Harborview Advisors, Ben Franklin Technology Partners of Pennsylvania and Harbor View Advisors.
Is Aprecia Pharmaceuticals a public company?
Aprecia Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Aprecia Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.